These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 24102786
1. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis. Burza MA, Molinaro A, Attilia ML, Rotondo C, Attilia F, Ceccanti M, Ferri F, Maldarelli F, Maffongelli A, De Santis A, Attili AF, Romeo S, Ginanni Corradini S. Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786 [Abstract] [Full Text] [Related]
2. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S. World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190 [Abstract] [Full Text] [Related]
3. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. Nischalke HD, Berger C, Luda C, Berg T, Müller T, Grünhage F, Lammert F, Coenen M, Krämer B, Körner C, Vidovic N, Oldenburg J, Nattermann J, Sauerbruch T, Spengler U. PLoS One; 2011 Jun 14; 6(11):e27087. PubMed ID: 22087248 [Abstract] [Full Text] [Related]
4. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. Kim HS, Xiao X, Byun J, Jun G, DeSantis SM, Chen H, Thrift AP, El-Serag HB, Kanwal F, Amos CI. JAMA Netw Open; 2022 Oct 03; 5(10):e2234221. PubMed ID: 36190732 [Abstract] [Full Text] [Related]
5. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population. Peregud DI, Baronets VY, Lobacheva AS, Ivanov AS, Arisheva OS, Garmash IV, Kobalava ZD, Pirozhkov SV, Terebilina NN. Ann Hepatol; 2021 Oct 03; 20():100247. PubMed ID: 32871288 [Abstract] [Full Text] [Related]
6. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. Burza MA, Pirazzi C, Maglio C, Sjöholm K, Mancina RM, Svensson PA, Jacobson P, Adiels M, Baroni MG, Borén J, Ginanni Corradini S, Montalcini T, Sjöström L, Carlsson LM, Romeo S. Dig Liver Dis; 2012 Dec 03; 44(12):1037-41. PubMed ID: 22704398 [Abstract] [Full Text] [Related]
7. PNPLA3 I148M polymorphism and progressive liver disease. Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. World J Gastroenterol; 2013 Nov 07; 19(41):6969-78. PubMed ID: 24222941 [Abstract] [Full Text] [Related]
8. Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C. De Nicola S, Dongiovanni P, Aghemo A, Cheroni C, D'Ambrosio R, Pedrazzini M, Marabita F, Donnici L, Maggioni M, Fargion S, Colombo M, De Francesco R, Valenti L. PLoS One; 2014 Nov 07; 9(8):e106022. PubMed ID: 25171251 [Abstract] [Full Text] [Related]
9. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Viganò M, Valenti L, Lampertico P, Facchetti F, Motta BM, D'Ambrosio R, Romagnoli S, Dongiovanni P, Donati B, Fargion S, Colombo M. Hepatology; 2013 Oct 07; 58(4):1245-52. PubMed ID: 23564580 [Abstract] [Full Text] [Related]
10. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. Pirazzi C, Adiels M, Burza MA, Mancina RM, Levin M, Ståhlman M, Taskinen MR, Orho-Melander M, Perman J, Pujia A, Andersson L, Maglio C, Montalcini T, Wiklund O, Borén J, Romeo S. J Hepatol; 2012 Dec 07; 57(6):1276-82. PubMed ID: 22878467 [Abstract] [Full Text] [Related]
11. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L. Hepatology; 2016 Mar 07; 63(3):787-98. PubMed ID: 26605757 [Abstract] [Full Text] [Related]
12. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. Palmer CN, Maglio C, Pirazzi C, Burza MA, Adiels M, Burch L, Donnelly LA, Colhoun H, Doney AS, Dillon JF, Pearson ER, McCarthy M, Hattersley AT, Frayling T, Morris AD, Peltonen M, Svensson PA, Jacobson P, Borén J, Sjöström L, Carlsson LM, Romeo S. PLoS One; 2012 Mar 07; 7(6):e39362. PubMed ID: 22724004 [Abstract] [Full Text] [Related]
13. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Stickel F, Buch S, Nischalke HD, Weiss KH, Gotthardt D, Fischer J, Rosendahl J, Marot A, Elamly M, Casper M, Lammert F, McQuillin A, Zopf S, Spengler U, Marhenke S, Kirstein MM, Vogel A, Eyer F, von Felden J, Wege H, Buch T, Schafmayer C, Braun F, Deltenre P, Berg T, Morgan MY, Hampe J. Am J Gastroenterol; 2018 Oct 07; 113(10):1475-1483. PubMed ID: 29535416 [Abstract] [Full Text] [Related]
14. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. Atkinson SR, Way MJ, McQuillin A, Morgan MY, Thursz MR. J Hepatol; 2017 Jul 07; 67(1):120-127. PubMed ID: 28161471 [Abstract] [Full Text] [Related]
15. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu. Nischalke HD, Lutz P, Bartok E, Krämer B, Langhans B, Frizler R, Berg T, Hampe J, Buch S, Datz C, Stickel F, Hartmann G, Strassburg CP, Nattermann J, Spengler U. J Mol Med (Berl); 2019 Nov 07; 97(11):1589-1600. PubMed ID: 31637480 [Abstract] [Full Text] [Related]
16. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P. Liver Int; 2011 Sep 07; 31(8):1137-43. PubMed ID: 21745286 [Abstract] [Full Text] [Related]
17. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. Trépo E, Gustot T, Degré D, Lemmers A, Verset L, Demetter P, Ouziel R, Quertinmont E, Vercruysse V, Amininejad L, Deltenre P, Le Moine O, Devière J, Franchimont D, Moreno C. J Hepatol; 2011 Oct 07; 55(4):906-12. PubMed ID: 21334404 [Abstract] [Full Text] [Related]
18. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma. Valenti L, Motta BM, Soardo G, Iavarone M, Donati B, Sangiovanni A, Carnelutti A, Dongiovanni P, Rametta R, Bertelli C, Facchetti F, Colombo M, Fargion S, Fracanzani AL. PLoS One; 2013 Oct 07; 8(10):e75982. PubMed ID: 24155878 [Abstract] [Full Text] [Related]
19. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival. Friedrich K, Wannhoff A, Kattner S, Brune M, Hov JR, Weiss KH, Antoni C, Dollinger M, Neumann-Haefelin C, Seufferlein T, Schemmer P, Schirmacher P, Stremmel W, Gotthardt DN. J Gastroenterol Hepatol; 2014 Oct 07; 29(7):1477-84. PubMed ID: 25273282 [Abstract] [Full Text] [Related]
20. A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis. Shankarappa B, Mahadevan J, Murthy P, Purushottam M, Viswanath B, Jain S, Devarbhavi H, Mysore V A. Indian J Gastroenterol; 2023 Dec 07; 42(6):800-807. PubMed ID: 37589914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]